MedPath

Ribose and Sport Performance

Not Applicable
Completed
Conditions
Sports
Interventions
Other: Placebo
Other: Ribose
Registration Number
NCT01727479
Lead Sponsor
Laval University
Brief Summary

Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Men and women
  • Training volume > 7hrs/week
  • VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
  • Otherwise healthy individuals
Exclusion Criteria
  • Pregnant or breastfeeding women
  • Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
  • Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
  • Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboAfter each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.
RiboseRiboseAfter each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.
Primary Outcome Measures
NameTimeMethod
Change in time to complete the third of 3 consecutive 3km time trials on bikebaseline and 1 week
Secondary Outcome Measures
NameTimeMethod
Performance on the 3 consecutive 3km time trials on bikebaseline and 1 week

Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)

Trial Locations

Locations (1)

Université Laval

🇨🇦

Québec, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath